Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

2003 • 25,662 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Prediction of Creatinine Clearance from Serum Creatinine

1976 • 15,066 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

1998 • 8,603 citations

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

2001 • 7,165 citations

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

2001 • 5,812 citations

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

1993 • 5,296 citations

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

1993 • 4,132 citations

2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*

2003 • 2,946 citations

2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

2003 • 2,534 citations

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

2000 • 2,085 citations

Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes

1984 • 1,939 citations

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

1998 • 1,435 citations

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

1998 • 1,333 citations

The Kidney: Structure and Function in Health and Disease

1952 • 1,326 citations

The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems

1990 • 723 citations

Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures

2001 • 488 citations

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study

1996 • 443 citations

Renal protective effect of enalapril in diabetic nephropathy.

1992 • 437 citations

Microalbuminuria: An Early Marker of Renal Involvement in Diabetes

1985 • 433 citations

INCREASED URINARY ALBUMIN-EXCRETION RATE IN BENIGN ESSENTIAL HYPERTENSION

1974 • 417 citations

Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM

1992 • 407 citations

Patterns of renal injury in NIDDM patients with microalbuminuria

1996 • 405 citations

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

1988 • 384 citations

National standard for measurement of resting and ambulatory blood pressures with automated sphygmomanometers.

1993 • 377 citations

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients

1991 • 358 citations

Long-term Renoprotective Effect of Angiotensin-converting Enzyme Inhibition in Non—insulin-dependent Diabetes Mellitus

1996 • 297 citations

Long-Term Effect of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy

1997 • 174 citations

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg

2000 • 173 citations

The Whitehall Study: Ten Year Follow-up Report on Men With Impaired Glucose Tolerance With Reference to Worsening to Diabetes and Predictors of Death

1984 • 100 citations

Laser immunonephelometry for routine quantification of urinary albumin excretion.

1987 • 96 citations

Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.

1993 • 81 citations

Enalapril

1992 • 79 citations

Impact of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy

1994 • 66 citations

Long-Term Treatment With Either Enalapril or Nitrendipine Stabilizes Albuminuria and Increases Glomerular Filtration Rate in Non- Insulin-Dependent Diabetic Patients

1994 • 64 citations

Screening for Diabetes Mellitus

1988 • 49 citations

Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria

1988 • 27 citations

Comparison of enalapril and bendrofluazide for treatment of systemic hypertension

1987 • 11 citations

[Non-invasive ambulatory measurement of arterial pressure. Recommendations of the measurement group of the French Society of Arterial Hypertension].

1993 • 9 citations

Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.

2003 • 6 citations

Reducing cardiovascular risk in diabetes

2007 • 6 citations